首页> 外文会议>Proceedings of the 4th international conference on product innovation management >Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation
【24h】

Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation

机译:美国生物技术制药企业发展路径研究及其启示

获取原文
获取原文并翻译 | 示例

摘要

Under the background of biotechnology pharmaceutical industries, the paper choosing four American biotechnology pharmaceutical enterprises as the research subjects: Amgen, Genentech, Biogen and Genzeme . Through analyzing the development course of these enterprises, three typical development paths zre concluded: self-development by means of traditional large-scale enterprises, self-integrated development and ―tie-core‖ incremental development. Meanwhile, the reasons why different enterprises choose different paths are analyzed. At last, revelations for China biotechnology enterprises development path are put forward based on above study and such suggestions aim at different enterprise type.
机译:在生物技术制药行业的背景下,本文选择了四个美国生物技术制药企业作为研究对象:Amgen,Genentech,Biogen和Genzeme。通过分析这些企业的发展历程,得出了三种典型的发展路径:传统大型企业的自我发展,自我整合的发展和“核心”的增量发展。同时,分析了不同企业选择不同路径的原因。最后,在上述研究的基础上,提出了对我国生物技术企业发展道路的启示,针对不同企业类型提出了建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号